Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes (MonoPepT1De)

This study has been completed.
Sponsor:
Collaborators:
Diabetes Vaccine Development Centre
Juvenile Diabetes Research Foundation
Information provided by (Responsible Party):
Professor Colin Dayan, Cardiff University
ClinicalTrials.gov Identifier:
NCT01536431
First received: February 14, 2012
Last updated: July 27, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)